TickerFactsScreenerDevelopers

Travere Therapeutics, Inc. (TVTX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $4.55M2017: $3.60M2018: $5.53M2019: $5.23M2020: $6.13M2021: $3.82M2022: $4.42M2023: $11.45M2024: $7.74M2025: $10.34M$10.34M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$10.34M+33.5%
2024$7.74M-32.4%
2023$11.45M+159.0%
2022$4.42M+15.8%
2021$3.82M-37.7%
2020$6.13M+17.0%
2019$5.23M-5.3%
2018$5.53M+53.3%
2017$3.60M-20.8%
2016$4.55M—